HPS Pharmacies wish to give notice that Seqirus is experiencing a supply interruption for BenPen™ as follows:
Benzylpenicillin (as sodium) 1.2g
Benzylpenicillin (as sodium) 3g
Normal supplies of BenPen™ 1.2g and 3g vials are expected to resume by mid-late August 2022. An internationally registered brand of benzylpenicillin 1.2g vials has been approved for supply under Section 19A of the Therapeutic Goods Act 1989.
Some wholesalers may also experience short-term supply interruptions for BenPen™ 600mg during this time. However, this product may be considered as a substitute where appropriate and available.
If a suitable presentation of benzylpenicillin is not available, an Infectious Disease specialist should be consulted for advice.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Seqirus on 1800 642 865, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates